Olema Pharmaceuticals Leases New South San Francisco HQ
about 9 hours ago
Olema Pharmaceuticals leased 38,000 square feet of office space in South San Francisco at Kilroy Realty's Phase 2 development at Kilroy Oyster Point for its new corporate headquarters, with plans for initial and future expansion. The lease spans seven years with options for extension and additional space. Kilroy Oyster Point Phase 2 includes multiple buildings totaling 865,000 square feet with amenities, and other major tenants include the University of California, San Francisco, a genomic sequencing foundry, and Acadia Pharmaceuticals. The development represents a $1.2 billion investment in office space in the San Francisco area.